12.21 USD
↗ 0.57 (4.90%)AT CLOSE (03:59 PM EDT)
Retension Pharmaceuticals, Inc. Common Stock
RTSNNASDAQ • USD
14.25
↗ 2.04 (16.71%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
14.25
↗ 2.04 (16.71%)
Market: OPEN
Shares of Retension Pharmaceuticals, Inc. Common Stock (RTSN) are trading at $14.25. The technical outlook is "Buy" based on moving average alignment, RSI, and MACD signals. This is driven by a bearish Death Cross on the long-term moving averages.
Technical & fundamental data as of Oct 15, 2026.
Open?$11.56
High?$12.86
Low?$11.56
Prev. Close?$11.64
Volume?131.0K
Avg. Volume?N/A
VWAP?$11.95
Bid / Ask
Bid?$11.76 × 100
Ask?$12.10 × 100
Spread?$0.34
Midpoint?$11.93
Valuation & Ratios
Market Cap?97.0M
Shares Out?N/A
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Retension Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases. Its product candidate, RTN-001, is a next-generation, once-daily, oral, small molecule phosphodiesterase-5 (PDE-5) inhibitor designed to reduce blood pressure.
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental Outlook
Loading...
Short Interest
Loading...